Cell cycle phase perturbations by 6-diazo-5-oxo-L-norleucine and acivicin in normal and neoplastic human cell lines

Br J Cancer. 1987 Jun;55(6):653-6. doi: 10.1038/bjc.1987.133.
No abstract available

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antimetabolites / metabolism
  • Antimetabolites / therapeutic use*
  • Azo Compounds / therapeutic use*
  • Cell Cycle / drug effects*
  • Cell Line
  • Colonic Neoplasms / drug therapy
  • Colonic Neoplasms / physiopathology
  • Diazooxonorleucine / metabolism
  • Diazooxonorleucine / therapeutic use*
  • Drug Evaluation, Preclinical
  • Glutaminase / metabolism
  • Glutamine / metabolism
  • Humans
  • Isoxazoles / metabolism
  • Isoxazoles / therapeutic use*
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / physiopathology
  • Neoplasms, Experimental / drug therapy*
  • Neoplasms, Experimental / physiopathology
  • Oxazoles / therapeutic use*

Substances

  • Antimetabolites
  • Azo Compounds
  • Isoxazoles
  • Oxazoles
  • Diazooxonorleucine
  • Glutamine
  • Glutaminase
  • acivicin